Drug intelligence / Profile preview

Lactiplantibacillus plantarum Lp05

Development stage: Preclinical
Lead developer: Wecare Probiotics
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Lactiplantibacillus plantarum Lp05 is a specific probiotic strain of live bacteria developed and manufactured by Wecare Probiotics Co., Ltd. [2-14, 4-13] It is classified as a probiotic biologic (live microorganism) and is being researched for its therapeutic potential. [2-14, 4-13] Clinical and preclinical studies are investigating its use in treating Helicobacter pylori infections and protecting against ethanol-induced liver injury. [1-4, 2-1, 4-3] The proposed mechanism of action involves modulating the gut microbiota, suppressing H. pylori through direct interaction, and consequently reducing associated inflammation and oxidative stress. [1-4, 2-6] Although it is being investigated for specific medical applications, as a probiotic strain, it is also available for use in dietary supplements and food products.

Other names: Lactobacillus plantarum Lp05植物乳植杆菌Lp05

Beyond the preview

Go deeper on Lactiplantibacillus plantarum Lp05.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lactiplantibacillus plantarum Lp05.

Explore the full profile